Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 7, Issue 22

November 28 2023

In this Issue

INSIDE BLOOD ADVANCES
CLINICAL GUIDELINES
CLINICAL TRIALS AND OBSERVATIONS
HEALTH SERVICES AND OUTCOMES
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY AND IMMUNOTHERAPY
LYMPHOID NEOPLASIA
MYELOID NEOPLASIA
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
RESEARCH LETTERS
COMMENTARY
ERRATA

INSIDE BLOOD ADVANCES

Ibrutinib in the treatment of relapsed FL and MZL?
Clinical Trials & Observations

Norbert Schmitz,Imke E. Karsten

View Articletitled, Ibrutinib in the treatment of relapsed FL and MZL?

Clearing the way for new therapies in clonal hematopoiesis

Victoria Y. Ling,Steven W. Lane

View Articletitled, Clearing the way for new therapies in clonal hematopoiesis

CLINICAL GUIDELINES

American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing

Saskia Middeldorp,Robby Nieuwlaat,Lisa Baumann Kreuziger,Michiel Coppens,Damon Houghton,Andra H. James,Eddy Lang,Stephan Moll,Tarra Myers,Meha Bhatt,Chatree Chai-Adisaksopha,Luis E. Colunga-Lozano,Samer G. Karam,Yuan Zhang,Wojtek Wiercioch,Holger J. Schünemann,Alfonso Iorio

View Articletitled, American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing

Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study
Clinical Trials & Observations

Stephen Opat,Alessandra Tedeschi,Bei Hu,Kim M. Linton,Pamela McKay,Sophie Leitch,Morton Coleman,Pier Luigi Zinzani,Jie Jin,Mingyuan Sun,Magdalena Sobieraj-Teague,Peter Browett,Xiaoyan Ke,Catherine Thieblemont,Kirit Ardeshna,Fontanet Bijou,Patricia Walker,Eliza A. Hawkes,Shir-Jing Ho,Keshu Zhou,Zhiyu Liang,Jianfeng Xu,Chris Tankersley,Richard Delarue,Melannie Co,Judith Trotman

View Articletitled, Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study

Supplemental data

Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma
Clinical Trials & Observations

Søren Thorgaard Bønløkke,Christian Fenger-Eriksen,Hans Beier Ommen,Anne-Mette Hvas

View Articletitled, Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma

Supplemental data

HEALTH SERVICES AND OUTCOMES

Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL

Constantine Tam,Javier Pinilla-Ibarz,Carolina G. Castillo,Ana Cristina Fenili,Kathryn Huntley,Volkan Karakus,Mervat Mattar,Miguel A. Miroli,Catherine Moura,Miguel Pavlovsky,Fernando Piotrowski,Martin Šimkovič,Stephan Stilgenbauer

View Articletitled, Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL

Supplemental data

HEMATOPOIESIS AND STEM CELLS

De novo hematopoiesis from the fetal lung

Anthony K. Yeung,Carlos Villacorta-Martin,Jonathan Lindstrom-Vautrin,Anna C. Belkina,Kim Vanuytsel,Todd W. Dowrey,Alexandra B. Ysasi,Pushpinder Bawa,Feiya Wang,Vladimir Vrbanac,Gustavo Mostoslavsky,Alejandro B. Balazs,George J. Murphy

View Articletitled, De novo hematopoiesis from the fetal lung

Supplemental data

Clearing and replacing tissue-resident myeloid cells with an anti-CD45 antibody–drug conjugate

Karin Gustafsson,Catherine Rhee,Vanessa Frodermann,Elizabeth W. Scadden,Dan Li,Yoshiko Iwamoto,Rahul Palchaudhuri,Sharon L. Hyzy,Anthony E. Boitano,Matthias Nahrendorf,David T. Scadden

View Articletitled, Clearing and replacing tissue-resident myeloid cells with an anti-CD45 antibody–drug conjugate

Supplemental data

Clearing the way for new therapies in clonal hematopoiesis

Victoria Y. Ling,Steven W. Lane

View Articletitled, Clearing the way for new therapies in clonal hematopoiesis

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation

Emily Landy,Jemy Varghese,Vinh Dang,Andrea Szymczak-Workman,Lawrence P. Kane,Scott W. Canna

View Articletitled, Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation

Supplemental data

LYMPHOID NEOPLASIA

HAPLN1 matrikine: a bone marrow homing factor linked to poor outcomes in patients with MM

Hae Yeun Chang,Mailee Huynh,Avtar Roopra,Natalie S. Callander,Shigeki Miyamoto

View Articletitled, HAPLN1 matrikine: a bone marrow homing factor linked to poor outcomes in patients with MM

Supplemental data

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
Clinical Trials & Observations

Emily C. Liang,Aya Albittar,Jennifer J. Huang,Alexandre V. Hirayama,Erik L. Kimble,Andrew J. Portuguese,Aude Chapuis,Mazyar Shadman,Brian G. Till,Ryan D. Cassaday,Filippo Milano,Hans-Peter Kiem,Stanley R. Riddell,Cameron J. Turtle,David G. Maloney,Jordan Gauthier

View Articletitled, Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL

Supplemental data

International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27

Simone Oerlemans,Fabio Efficace,Omar Shamieh,Fabio Cardoso Borges,Corine de Jong,Dong Dong,Jens Lehmann,Sandra Malak,Duska Petranovic,Christian W. Scholz,Giovanni Caocci,Stefano Molica,Laimonas Griskevicius,Eva Nagele,Anne Bredart,Elisabete Carvalho,Aliki Xochelli,Joost Agelink van Rentergem,Waleed Alrjoob,Anja Mueller,Ana Carolina Freitas,Kim Cocks,Carien Creutzberg,Charalampia Kyriakou,Lonneke van de Poll-Franse

View Articletitled, International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27

Supplemental data

Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations

Tanmaya Atre,Ali Farrokhi,Sumin Jo,Samuel Salitra,Jesus Duque-Afonso,Michael L. Cleary,Nina Rolf,Gregor S. D. Reid

View Articletitled, Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations

Supplemental data

Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma
Clinical Trials & Observations

Loretta J. Nastoupil,Georg Hess,Miguel A. Pavlovsky,Iwona Danielewicz,Jane Freeman,Alejandro Martin García-Sancho,Valeria Glazunova,Andrew Grigg,Jing-Zhou Hou,Ann Janssens,Seok Jin Kim,Zvenyslava Masliak,Pam McKay,Francesco Merli,Wataru Munakata,Hirokazu Nagai,Muhit Özcan,Meir Preis,Tingyu Wang,Melissa Rowe,Monelle Tamegnon,Rui Qin,Todd Henninger,Madeliene Curtis,Donne Bennett Caces,Catherine Thieblemont,Gilles Salles

View Articletitled, Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma

Supplemental data

Ibrutinib in the treatment of relapsed FL and MZL?
Clinical Trials & Observations

Norbert Schmitz,Imke E. Karsten

View Articletitled, Ibrutinib in the treatment of relapsed FL and MZL?

MYELOID NEOPLASIA

Vitamin C and D supplementation in acute myeloid leukemia
Clinical Trials & Observations

Pierre Luc Mouchel,Emilie Bérard,Suzanne Tavitian,Noémie Gadaud,François Vergez,Jean Baptiste Rieu,Isabelle Luquet,Audrey Sarry,Françoise Huguet,Laetitia Largeaud,Eric Delabesse,Anne Huynh,Sarah Bertoli,Christian Récher

View Articletitled, Vitamin C and D supplementation in acute myeloid leukemia

Supplemental data

Impact of preexisting autoimmune disease on myelodysplastic syndromes outcomes: a population analysis

Diego Adrianzen-Herrera,Andrew D. Sparks,Rohit Singh,David Alejos-Castillo,Akshee Batra,Shira Glushakow-Smith,Kith Pradhan,Aditi Shastri,Neil A. Zakai

View Articletitled, Impact of preexisting autoimmune disease on myelodysplastic syndromes outcomes: a population analysis

Supplemental data

Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia

Luiz Fernando B. Catto,Leonardo C. Zanelatto,Flavia S. Donaires,Vinicius S. de Carvalho,Bárbara A. Santana,André L. Pinto,Daianne Fantacini,Lucas Eduardo B. de Souza,Natasha P. Fonseca,Bruno S. Telho,Maria Isabel Ayrosa Madeira,Katia Borgia Barbosa Pagnano,Ana Beatriz Firmato,Evandro Maranhão Fagundes,Marcia Higashi,Elenaide Coutinho Nunes,Fabiola Traina,Lorena Lobo de F. Pontes,Eduardo M. Rego,Rodrigo T. Calado

View Articletitled, Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia

Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Natural history and variability in albuminuria in pediatric and murine sickle cell anemia

Malgorzata Kasztan,Inmaculada Aban,Kayla Baker,Michael Ho,Chibuzo Ilonze,Jeffrey Lebensburger

View Articletitled, Natural history and variability in albuminuria in pediatric and murine sickle cell anemia

Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis

Raymond Liang,Miao Lin,Vijay Menon,Jiajing Qiu,Anagha Menon,Laura Breda,Tasleem Arif,Stefano Rivella,Saghi Ghaffari

View Articletitled, Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis

Supplemental data

Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries
Global Advances

Lauren Jane Klein,Shehu Umar Abdullahi,Safiya Gambo,Virginia A. Stallings,Sari Acra,Mark Rodeghier,Michael R. DeBaun

View Articletitled, Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries

Supplemental data

THROMBOSIS AND HEMOSTASIS

VWF–ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion

Helen Fogarty,Azaz Ahmad,Ferdows Atiq,Dearbhla Doherty,Soracha Ward,Ellie Karampini,Aisling Rehill,Gemma Leon,Ciara Byrne,Rosena Geoghegan,Helena Conroy,Mary Byrne,Ulrich Budde,Sonja Schneppenheim,Ciara Sheehan,Noel Ngwenya,Ross I. Baker,Roger J. S. Preston,Emma Tuohy,Corrina McMahon,James S. O’Donnell

View Articletitled, VWF–ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion

Supplemental data

Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia A

Takafumi Hiramoto,Hiroshi Inaba,Nemekhbayar Baatartsogt,Yuji Kashiwakura,Morisada Hayakawa,Nobuhiko Kamoshita,Hiroshi Nishimasu,Osamu Nureki,Ei Kinai,Tsukasa Ohmori

View Articletitled, Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia A

Supplemental data

TRANSPLANTATION

Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis

Mallory R. Taylor,Steve W. Cole,Joelle Strom,Ruta Brazauskas,K. Scott Baker,Rachel Phelan,David Buchbinder,Betty Hamilton,Hélène Schoemans,Bronwen E. Shaw,Akshay Sharma,Neel S. Bhatt,Sherif M. Badawy,Lena E. Winestone,Jaime M. Preussler,Samantha Mayo,Kareem Jamani,Taiga Nishihori,Michelle A. Lee,Jennifer M. Knight

View Articletitled, Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis

Supplemental data

Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation

Masahiro Miyata,Eri Matsuki,Kazunobu Ichikawa,Tomohiro Takehara,Yuka Hosokawa,Erika Sekiguchi,Daniel Peltier,Pavan Reddy,Kenichi Ishizawa,Masafumi Watanabe,Tomomi Toubai

View Articletitled, Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation

Supplemental data

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
Clinical Trials & Observations

Hemant S. Murthy,Mei-Jie Zhang,Karen Chen,Sairah Ahmed,Uday Deotare,Siddhartha Ganguly,Ankit Kansagra,Fotios V. Michelis,Taiga Nishihori,Mrinal Patnaik,Muhammad Bilal Abid,Mahmoud Aljurf,Yasuyuki Arai,Ulrike Bacher,Talha Badar,Sherif M. Badawy,Karen Ballen,Minoo Battiwalla,Amer Beitinjaneh,Nelli Bejanyan,Vijaya Raj Bhatt,Valerie I. Brown,Rodrigo Martino,Jean-Yves Cahn,Paul Castillo,Jan Cerny,Saurabh Chhabra,Edward Copelan,Andrew Daly,Bhagirathbhai Dholaria,Miguel Angel Diaz Perez,César O. Freytes,Michael R. Grunwald,Shahrukh Hashmi,Gerhard C. Hildebrandt,Omer Jamy,Jacinth Joseph,Christopher G. Kanakry,Nandita Khera,Maxwell M. Krem,Yachiyo Kuwatsuka,Hillard M. Lazarus,Lazaros J. Lekakis,Hongtao Liu,Dipenkumar Modi,Pashna N. Munshi,Alberto Mussetti,Neil Palmisiano,Sagar S. Patel,David A. Rizzieri,Sachiko Seo,Mithun Vinod Shah,Akshay Sharma,Melhm Sohl,Scott R. Solomon,Matthew Ulrickson,Celalettin Ustun,Marjolein van der Poel,Leo F. Verdonck,John L. Wagner,Trent Wang,Baldeep Wirk,Amer Zeidan,Mark Litzow,Partow Kebriaei,Christopher S. Hourigan,Daniel J. Weisdorf,Wael Saber,Mohamed A. Kharfan-Dabaja

View Articletitled, Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

Supplemental data

Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS report

Nora Balas,Joshua Richman,Wendy Landier,Sadeep Shrestha,Katia J. Bruxvoort,Lindsey Hageman,Qingrui Meng,Elizabeth Ross,Alysia Bosworth,Hok Sreng Te,F. Lennie Wong,Ravi Bhatia,Stephen J. Forman,Saro H. Armenian,Daniel J. Weisdorf,Smita Bhatia

View Articletitled, Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS report

Supplemental data

RESEARCH LETTERS

Intrapatient competition of VEXAS syndrome and CML clones

Nadia Djerbi,Kathrin Zimmermann,Marco Roncador,Mike Oliver Becker,Markus G. Manz,Stefan Balabanov

View Articletitled, Intrapatient competition of VEXAS syndrome and CML clones

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study
Clinical Trials & Observations

Kaitlin Annunzio,Natalie S. Grover,Rina Li Welkie,Pallawi Torka,Marcus P. Watkins,Andrea Anampa-Guzmán,Montreh Tavakkoli,Timothy S. Oh,Heather Reves,Daniel Jones,Walter Hanel,Beth Christian,Praveen Ramakrishnan Geethakumari,Reem Karmali,Stefan K. Barta,Nancy L. Bartlett,Adam J. Olszewski,Narendranath Epperla

View Articletitled, Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

Supplemental data

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL

Viktoria Blumenberg,Galina Busch,Stephan Baumann,Regina Jitschin,Gloria Iacoboni,Laura Gallur,Josu Iraola-Truchuelo,Eva Hoster,Michael Winkelmann,Konstantin Hellwig,Christian Schmidt,Lisa Frölich,Benjamin Tast,Friederike Hildebrand,Kai Rejeski,Franziska Dekorsy,Christian Schmidkonz,Tobias Bäuerle,Wolfgang G. Kunz,Dimitrios Mougiakakos,Fabian Müller,Michael von Bergwelt-Baildon,Pere Barba,Veit L. Bücklein,Andreas Mackensen,Simon Völkl,Marion Subklewe

View Articletitled, Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL

Supplemental data

Intensive hydroxyurea dosing in very young children with sickle cell anemia
Clinical Trials & Observations

Winfred C. Wang,R. Clark Brown,Melissa A. McNaull,Zora R. Rogers,Martha Barton,Meghna R. Dua,Jane S. Hankins,Jeffrey Gossett,Julie Richardson,Jerlym S. Porter,Guolian Kang,Jeremie H. Estepp,for the HUGKISS Investigators

View Articletitled, Intensive hydroxyurea dosing in very young children with sickle cell anemia

Supplemental data

Progenitor-like cell type of an MLL-EDC4 fusion in acute myeloid leukemia

Linda C. Schuster,Afzal P. Syed,Stephan M. Tirier,Simon Steiger,Isabelle Seufert,Heiko Becker,Jesus Duque-Afonso,Tobias Ma,Seishi Ogawa,Jan-Philipp Mallm,Michael Lübbert,Karsten Rippe

View Articletitled, Progenitor-like cell type of an MLL-EDC4 fusion in acute myeloid leukemia

Supplemental data

Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm: a 2-speed cure in the United States and European Union

Caterina Giovanna Valentini,Livio Pagano

View Articletitled, Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm: a 2-speed cure in the United States and European Union

COMMENTARY

World Coalition on SCD launches, sparking global focus on SCD diagnosis and care

Andrew Zapfel,Alexis Thompson,Kenneth Bridges,Juliana Richardson,Lwimba Kasongo,Christophe Przybylski,Charles Kiyaga,Prebo Barango,Isaac Odame

View Articletitled, World Coalition on SCD launches, sparking global focus on SCD diagnosis and care

ERRATA

Schuelke MR, Bassiri H, Behrens EM, et al. Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients. Blood Adv. 2023;7(18):5603–5607.

View Articletitled, Schuelke MR, Bassiri H, Behrens EM, et al. Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients. Blood Adv. 2023;7(18):5603–5607.

DeFilipp Z, Kim HT, Yang Z, et al. Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials. Blood Adv. 2022;6(24):6263-6270.

View Articletitled, DeFilipp Z, Kim HT, Yang Z, et al. Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials. Blood Adv. 2022;6(24):6263-6270.

DuMontier C, La J, Bihn J, et al. More intensive therapy has a better effect for frail parents with multiple myeloma. Blood Adv. 2023;7(20):6275-6284.

View Articletitled, DuMontier C, La J, Bihn J, et al. More intensive therapy has a better effect for frail parents with multiple myeloma. Blood Adv. 2023;7(20):6275-6284.

Cover Image

Cover Image

Immunofluorescent staining of a postconception 20-week-old human fetal lung showing a cluster of CD41 expressing cells (green) undergoing endothelial-to-hematopoietic transition (EHT) from neighboring vascular endothelial cadherin-positive endothelium (red). These clusters are also expressing the key EHT transcriptional regulator RUNX-1 (gray), thus suggesting the presence of hemogenic endothelium in the fetal lung. See the article by Yeung et al.
Front Matter
Editorial Board

All Issues

Email alerts

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read
Most Cited

Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy

Phillips NS, Mulrooney DA, Williams AM, et al. Neurocognitive impairment associated with chronic morbidity in long-term survivors of Hodgkin Lymphoma. Blood Adv. 2023;7(23):7270-7278.

Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon

A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia

Race and ethnicity reporting and representation in hemophilia clinical trials

Issue Archive

Table of Contents

INSIDE BLOOD ADVANCES

Ibrutinib in the treatment of relapsed FL and MZL? Clinical Trials & Observations

CLINICAL GUIDELINES

CLINICAL TRIALS AND OBSERVATIONS

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study Clinical Trials & Observations

Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma Clinical Trials & Observations

HEALTH SERVICES AND OUTCOMES

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL Clinical Trials & Observations

Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma Clinical Trials & Observations

Ibrutinib in the treatment of relapsed FL and MZL? Clinical Trials & Observations

MYELOID NEOPLASIA

Vitamin C and D supplementation in acute myeloid leukemia Clinical Trials & Observations

RED CELLS, IRON, AND ERYTHROPOIESIS

Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries Global Advances

THROMBOSIS AND HEMOSTASIS

TRANSPLANTATION

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis Clinical Trials & Observations

RESEARCH LETTERS

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study Clinical Trials & Observations

Intensive hydroxyurea dosing in very young children with sickle cell anemia Clinical Trials & Observations

COMMENTARY

ERRATA

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

Ibrutinib in the treatment of relapsed FL and MZL?
Clinical Trials & Observations

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study
Clinical Trials & Observations

Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma
Clinical Trials & Observations

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
Clinical Trials & Observations

Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma
Clinical Trials & Observations

Ibrutinib in the treatment of relapsed FL and MZL?
Clinical Trials & Observations

Vitamin C and D supplementation in acute myeloid leukemia
Clinical Trials & Observations

Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries
Global Advances

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
Clinical Trials & Observations

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study
Clinical Trials & Observations

Intensive hydroxyurea dosing in very young children with sickle cell anemia
Clinical Trials & Observations